Jubilant Ingrevia Limited
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
What Jubilant files
- Others85
- Important54
- Investor Meet39
- Updates38
- Dividend/Bonus21
- QIP/Rights/Pref.21
Jubilant Ingrevia's 7th AGM approved all resolutions, including the adoption of FY26 standalone and consolidated financial results. Shareholders also declared a final dividend of Rs. 2.50 per equity share, totaling approximately Rs. 39.82 Cr.
Jubilant Ingrevia Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 26, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
Jubilant Ingrevia is acquiring a 40% strategic stake in Zettaone Technologies, an electronics design and manufacturing platform, for ₹189.2 Cr. This move expands its presence in Electronics Development and Manufacturing Services (EDMS), aligning with its Pinnacle growth strategy and strengthening its electronics/semiconductor value chain.
Jubilant Ingrevia acquires a 40% strategic stake in Zettaone Technologies for ₹189.2 Cr. This move expands its footprint into Electronics Development & Manufacturing Services (EDMS) and the semiconductor sector, leveraging existing CDMO capabilities.
Jubilant Ingrevia's management will attend the Equirus Annual India Conference 2026 in Mumbai on August 13th & 14th. They will hold in-person one-on-one meetings with investors and analysts. Discussions will cover generally available company information.